Reduce IDentified UNcontrolled Asthma

The purpose of Reduce IDentified UNcontrolled Asthma (RIDUNA) is to determine the benefit of real-time identification of uncontrolled asthma by electronic administrative records linked to real-time notification of uncontrolled status to patients and asthma specialists with recommended guideline directed intervention by physicians. The investigators hypothesize that real-time outreach following National guideline asthma care recommendations, after real-time identification of an uncontrolled asthma event in persistent asthmatics on inhaled corticosteroids will lead to better improvements in asthma control (impairment and risk) compared to standard asthma care outreach.

Inclusion Criteria: KPSC members at time of uncontrolled event: 1. 12-56 years of age 2. Continuously enrolled and with pharmacy benefit for the past year 3. Dispensed inhaled corticosteroid (ICS) in the past 6 months. 4. Uncontrolled asthma: defined within the past year * Impairment cohort: 7th short-acting beta-agonist (SABA) canister dispensed and/or * Risk (exacerbation) cohort: 2nd oral corticosteroid (OCS)dispensing with provider asthma exacerbation encounter within 2 days and at least 1 month after the first OCS dispensing. Exclusion Criteria: * Patients with chronic obstructive lung disease, * emphysema, * cystic fibrosis, * chronic bronchitis, * bronchiectasis, * Churg Strauss, * Wegener's, * sarcoidosis, * pulmonary hypertension or other clinically relevant non-asthma pulmonary disorder such as autoimmunity, * immune deficiency, * cancer, * HIV, * steroid dependent asthma, * omalizumab therapy within the past 3 months, and * requirement for an interpreter.